Nair Abhijit, Bodhey Abhay, Jabri Ahmed A, Al Sawafi Faisal, Dudhedia Ujjwalraj I
Anesthesiology, Ibra Hospital, Ibra, OMN.
Anesthesiology, Rashid Hospital, Dubai, ARE.
Cureus. 2024 Nov 15;16(11):e73759. doi: 10.7759/cureus.73759. eCollection 2024 Nov.
Non-steroidal anti-inflammatory drugs (NSAIDs) are popularly used in the management of acute postoperative pain. Intravenous (IV) ketorolac has been used for several years for this purpose. Recently, IV ibuprofen has been introduced for the management of postoperative pain. This review aims to compare the efficacy of these two NSAIDs in managing acute postoperative pain. After registering the protocol in the International Prospective Register of Systematic Reviews (PROSPERO), databases like PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Ovid were searched using relevant keywords. Twenty-four-hour opioid consumption was the primary outcome. Pain scores, patient satisfaction, rescue analgesia requirements, and adverse events were the secondary outcomes assessed. Out of 124 articles that were retrieved, six articles fulfilled the inclusion criteria. The Risk of Bias 2 (RoB-2) was used for risk of bias assessment, Review Manager (RevMan) was used for a quantitative meta-analysis, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to assess the strength of evidence. The risk of bias was high in all categories. The 24-hour opioid requirement, which was the primary outcome, was comparable between both groups (mean difference: -4.72; 95% CI: -5.65, -3.80; P=0.79), with significant heterogeneity (I=93%). The secondary outcomes were comparable among both groups. The Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) strength of evidence was moderate for the pain score at movement and low to very low for other outcomes. Based on the results of this review, the efficacy of IV ibuprofen and IV ketorolac are comparable. However, the findings should be interpreted with caution due to significant clinical and statistical heterogeneity. Well-designed, adequately powered studies need to be conducted to find out the dose, frequency, and type of surgery suitable for various NSAIDs.
非甾体抗炎药(NSAIDs)广泛用于术后急性疼痛的管理。静脉注射酮咯酸已用于此目的数年。最近,静脉注射布洛芬已被用于术后疼痛的管理。本综述旨在比较这两种NSAIDs在管理术后急性疼痛方面的疗效。在国际前瞻性系统评价注册库(PROSPERO)中注册方案后,使用相关关键词检索了PubMed、Cochrane对照试验中央注册库(CENTRAL)、护理及相关健康文献累积索引(CINAHL)和Ovid等数据库。24小时阿片类药物消耗量是主要结局。疼痛评分、患者满意度、补救镇痛需求和不良事件是评估的次要结局。在检索到的124篇文章中,有6篇文章符合纳入标准。使用偏倚风险2(RoB-2)进行偏倚风险评估,使用Review Manager(RevMan)进行定量荟萃分析,并使用推荐分级评估、制定和评价(GRADE)来评估证据强度。所有类别中的偏倚风险都很高。作为主要结局的24小时阿片类药物需求量在两组之间具有可比性(平均差异:-4.72;95%CI:-5.65,-3.80;P=0.79),存在显著异质性(I=93%)。次要结局在两组之间具有可比性。对于运动时的疼痛评分,推荐分级评估、制定和评价(GRADE)证据强度为中等,对于其他结局则为低至极低。基于本综述的结果,静脉注射布洛芬和静脉注射酮咯酸的疗效相当。然而,由于存在显著的临床和统计异质性,这些发现应谨慎解释。需要进行设计良好、样本量充足的研究,以找出适合各种NSAIDs的剂量、频率和手术类型。